Genomic imprinting and chromatin insulation in Beckwith-Wiedemann syndrome

Applied Biochemistry and Biotechnology - Part B Molecular Biotechnology

Volumn 11, Issue 2, 1999, Pages 159-173

  Greally, John M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Beckwith Weidemann syndrome; Chromatin; Chromosome abnormalities; CpG islands; Genomic imprinting; Heterochromatin; Insulin like growth factor II

Indexed keywords

CIS ACTING ELEMENT; SOMATOMEDIN B;

BECKWITH WIEDEMANN SYNDROME; CHROMOSOME 11P; CHROMOSOME ABERRATION; CPG ISLAND; GENE EXPRESSION REGULATION; GENE LOCUS; GENOME IMPRINTING; HETEROCHROMATIN; HETEROZYGOSITY LOSS; REGULATORY MECHANISM; REVIEW; TRANSGENE;

MAMMALIA;

EID: 0032782842     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02915809     Document Type: Review

References (125)

1. Holliday, R. (1990) Genomic imprinting and allelic exclusion. Dev. Suppl. 125-129.
2. Chess, A. (1998) Expansion of the allelic exclusion principle? Science 279, 2067-2068.
3. Glenn, C. C., Driscoll, D. J., Yang, T. P., and Nicholls, R. D. (1997) Genomic imprinting: Potential function and mechanisms revealed by the Prader-Willi and Angelman syndromes. Mol. Hum. Reprod. 3, 321-332.
4. Tycko, B., Trasler, J., and Bestor, T. (1997) Genomic imprinting: Gametic mechanisms and somatic consequences. J. Androl. 18, 480-486.
5. Feil, R. and Kelsey, G. (1997) Genomic imprinting: A chromatin connection. Am. J. Hum. Genet. 61, 1213-1219.
6. Bartolomei, M. S. and Tilghman, S. M. (1997) Genomic imprinting in mammals. Annu. Rev. Genet. 31, 493-525.
7. Giddings, S. J., King, C. D., Harman, K. W., Flood, J. F., and Carnaghi, L. R. (1994) Allele specific inactivation of insulin 1 and 2, in the mouse yolk sac, indicates imprinting. Nature Genet. 6, 310-313.
8. Tycko, B. (1994) Genomic imprinting: Mechanism and role in human pathology. Am. J. Pathol. 144, 431-443.
9. Rainier, S. and Feinberg, A. P. (1994) Genomic imprinting, DNA methylation, and cancer. J. Natl. Cancer Inst. 86, 753-759.
10. Junien, C. and Henry, I. (1994) Genetics of Wilms' tumor: A blend of aberrant development and genomic imprinting. Kidney Int. 46, 1264-1279.
11. McCaffrey, T. V., Meyer, F. B., Michels, V. V., Piepgras, D. G., and Marion, M. S. (1994) Familial paragangliomas of the head and neck. Arch. Otolaryngol. Head Neck Surg. 120, 1211-1216.
12. Feinberg, A. P., Rainier, S., and DeBaun, M. R. (1995) Genomic imprinting, DNA methylation, and cancer. J. Natl. Cancer Inst. Monogr. 17, 21-26.
13. Ohlsson, R. and Franklin, G. (1995) Normal development and neoplasia: The imprinting connection. Int. J. Dev. Biol. 39, 869-876.
14. Squire, J. and Weksberg, R. (1996) Genomic imprinting in tumors. Semin. Cancer Biol. 7, 41-47.
15. Feinberg, A. P. (1996) Multiple genetic abnormalities of 11p15 in Wilms' tumor. Med. Pediatr. Oncol. 27, 484-489.
16. Fleming, S. (1997) Genetics of renal tumors. Cancer Metast. Rev. 16, 127-140.
17. Schuffenhauer, S., Bartsch, O., Stumm, M., Buchholz, T., Petropoutou, T., Kraft, S., Belohradsky, B., Hinkel, G. K., Meitinger, T., and Wegner, R. D. (1995) DNA, FISH and complementation studies in ICF syndrome: DNA hypomethylation of repetitive and single copy loci and evidence for a trans acting factor. Hum. Genet. 96, 562-571.
18. Li, M., Squire, J. A., and Weksberg, R. (1997) Molecular genetics of Beckwith-Wiedemann syndrome. Curr. Opin. Pediatr. 9, 623-629.
19. van der Mey, A. G., Maaswinkel-Mooy, P. D., Cornelisse, C. J., Schmidt, P. H., and van de Kamp, J. J. (1989) Genomic imprinting in hereditary glomus tumors: Evidence for new genetic theory. Lancet 2, 1291-1294.
20. Heutink, P., van der Mey, A. G., Sandkuijl, L. A., van Gils, A. P., Bardoel, A., Breedveld, G. J., van Vlict, M., van Ommen, G. J., Cornelisse, C. J., Oostra, B. A., et al. (1992) A gene subject to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23-qter. Hum. Mol. Genet. 1, 7-10.
21. Nicholls, R. D. (1993) Genomic imprinting and uniparental disomy in Angelman and Prader-Willi syndromes: A review. Am. J. Med. Genet. 46, 16-25.
22. Pedone, P. V., Tirabosco, R., Cavazzana, A. O., Ungaro, P., Basso, G., Luksch, R., Carli, M., Bruni, C. B., Frunzio, R., and Riccio, A. (1994) Mono- and bi-allelic expression of insulin-like growth factor II gene in human muscle tumors. Hum. Mol. Genet. 3, 1117-1121.
23. Montagna, M., Menin, C., Chieco-Bianchi, L., and D'Andrea, E. (1994) Occasional loss of constitutive heterozygosity at 11p15.5 and imprinting relaxation of the IGFH maternal allele in hepatoblastoma. J. Cancer Res. Clin. Oncol. 120, 732-736.
24. Walsh, C., Miller, S. J., Flam, F., Fisher, R. A., and Ohlsson, R. (1995) Paternally derived H19 is differentially expressed in malignant and nonmalignant trophoblast. Cancer Res. 55, 1111-1116.
25. Vu, T. H., Yballe, C., Boonyanit, S., and Hoffman, A. R. (1995) Insulin-like growth factor II in uterine smooth-muscle tumors: Maintenance of genomic imprinting in leiomyomata and loss of imprinting in leiomyosarcomata. J. Clin. Endocrinol. Metab. 80, 1670-1676.
26. Weksberg, R. and Squire, J.A. (1996) Molecular biology of Beckwith-Wiedemann syndrome. Med. Pediatr. Oncol. 27, 462-469.
27. Reeve, A. E., Housiaux, P. J., Gardner, R. J., Chewings, W. E., Grindley, R. M., and Millow, L. J. (1984) Loss of a Harvey ras allele in sporadic Wilms' tumor. Nature 309, 174-176.
28. Weksberg, R., Teshima, I., Williams, B. R., Greenberg, C. R., Pueschel, S. M., Chernos, J. E., Fowlow, S. B., Hoyme, E., Anderson, I. J., Whiteman, D. A., et al. (1993) Molecular characterization of cytogenetic alterations associated with the Beckwith-Wiedemann syndrome (BWS) phenotype refines the localization and suggests the gene for BWS is imprinted. Hum. Mol. Genet. 2, 549-556.
29. Sait, S. N., Nowak, N. J., Singh-Kahlon, P., Weksberg, R., Squire, J., Shows, T. B., and Higgins, M.J. (1994) Localization of Beckwith-Wiedemann and rhabdoid tumor chromosome rearrangements to a defined interval in chromosome band 11p15.5. Genes Chrom. Cancer 11, 97-105.
30. Mannens, M., Hoovers, J. M., Redeker, E., Verjaal, M., Feinberg, A. P., Little, P., Boavida, M., Coad, N., Steenman, M., Blick, J., et al. (1994) Parental imprinting of human chromosome region 11p15.3-pter involved in the Beckwith-Wiedemann syndrome and various human neoplasia. Eur. J. Hum. Genet. 2, 3-23.
31. Hoovers, J. M., Kalikin, L. M., Johnson, L. A., Alders, M, Redeker, Law, D. J., Bliek, J., Steenman, M., Benedict, M., and Wiegant, J. (1995) Multiple genetic loci within 11p15 defined by Beckwith-Wiedemann syndrome rearrangement breakpoints and subchromosomal transferable fragments. Proc. Natl. Acad. Sci. USA 92, 12,456-12,460.
32. Hatada, I., Ohashi, H., Fukushima, Y., Kaneko, Y., Inoue, M., Komoto, Y., Okada, A., Ohishi, S., Nabetani, A., Morisaki, H., Nakayama, M., Niikawa, N., and Mukai, T. (1996) An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome. Nature Genet. 14, 171-173.
33. Malsuoka, S., Edwards, M. C., Bai, C., Parker, S., Zhang, P., Baldini, A., Harper, J. W., and Elledge, S. J. (1995) p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9, 650-662.
34. Zhang, P., Liegeois, N. J., Wong, C., Finegold, M., Hou, H., Thompson, J. C., Silverman, A., Harper, J. W., DePinho, R. A., and Elledge, S. J. (1997) Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387, 151-158.
35. Yan, Y., Frisen, J., Lee, M. H., Massague, J., and Barbacid, M. (1997) Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev. 11, 973-983.
36. Eggenschwiler, J., Ludwig, T., Fisher, P., Leighton, P. A., Tilghman, S. M., and Efstratiadis, A. (1997) Mouse mutant embryos overexprcssing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes. Genes Dev. 11, 3128-3142.
37. DeChiara, T. M., Efstratiadis, A., and Robertson, E. J. (1990) A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345, 78-80.
38. Weksberg, R., Shen, D. R., Fei, Y. L., Song, Q. L., and Squire, J. (1993) Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nature Genet. 5, 143-150.
39. Ogawa, O., Becroft, D. M., Morison, I. M., Eccles, M. R., Skeen, J. E., Mauger, D. C., and Reeve, A. E. (1993) Constitutional relaxation of insulin-like growth factor II gene imprinting associated with Wilms' tumor and gigantism. Nature Genet. 5, 408-412.
40. Brown, K. W., Villar, A. J., Bickmore, W., Clayton-Smith, J., Catchpoole, D., Maher, E. R., and Reik, W. (1996) Imprinting mutation in the Beckwith-Wiedemann syndrome leads to biallelic IGF2 expression through an H19-independent pathway. Hum. Mol. Genet. 5, 2027-2032.
41. Joyce, J. A., Lam, W. K., Catchpoole, D. J., Jenks, P., Reik, W., Maher, E. R., and Schofield, P. N. (1997) Imprinting of IGF2 and H19: Lack of reciprocity in sporadic Beckwith-Wiedemann syndrome. Hum. Mol. Genet. 6, 1543-1548.
42. Vu, T. H., Yballe, C., Boonyanit, S., and Hoffman, A.R. (1995) Insulin-like growth factor II in uterine smooth-muscle tumors: Maintenance of genomic imprinting in leiomyomata and loss of imprinting in leiomyosarcomata. J. Clin. Endocrinol. Metab. 80, 1670-1676.
43. Zhan, S., Shapiro, D. N., and Helman, L. J. (1995) Loss of imprinting of IGF2 in Ewing's sarcoma. Oncogene 11, 2503-2507.
44. Doue-Rasy, S., Barrois, M., Fogel, S., Ahomadegbe, J. C., Stehelin, D., Coll, J., and Riou, G. (1996) High incidente of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19. Oncogene 12, 423-430.
45. McCann, A. H., Miller, N., O'Meara, A., Pedersen, I., Keogh, K., Gorey, T., and Dervan, P. A. (1996) Biallelic expression of the IGF2 gene in human breast disease. Hum. Mol. Genet. 5, 1123-1127.
46. Kinouchi, Y., Hiwatashi, N., Higashioka, S., Nagashima, F., Chida, M., and Toyota, T. (1996) Relaxation of imprinting of the insulin-like growth factor II gene in colorectal cancer. Cancer Lett. 107, 105-108.
47. Uyeno, S., Aoki, Y., Nata, M., Sagisaka, K., Kayama, T., Yoshimoto, T., and Ono, T. (1996) IGF2 but not H19 shows loss of imprinting in human glioma. Cancer Res. 56, 5356-5359.
48. Wu, H. K., Weksberg, R., Minden, M. D., and Squire, J. A. (1997) Loss of imprinting of human insulin-like growth factor II gene, IGF2, in acute myeloid leukemia. Biochem. Biophys. Res. Commun. 231, 466-472.
49. Nonomura, N., Miki, T., Nishimura, K., Kanno, N., Kojima, Y., and Okuyama, A. (1997) Altered imprinting of the H19 and insulin-like growth factor II genes in testicular tumors. J. Urol. 157, 1977-1979.
50. Wu, H. K., Squire, J. A., Catzavelos, C. G., and Weksberg, R. (1997) Relaxation of imprinting of human insulin-like growth factor II gene, IGF2, in sporadic breast carcinomas. Biochem. Biophys. Res. Commun. 235, 123-129.
51. Oda, H., Kume, H., Shimizu, Y., Inoue, T. and Ishikawa, T. (1998) Loss of imprinting of IGF2 in renal-cell carcinomas. Int. J. Cancer 75, 343-346.
52. Kim, K. S. and Lee, Y. I. (1997) Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma. Cancer Lett. 119, 143-148.
53. Wu, M. S., Wang, H. P., Lin, C. C., Sheu, J. C., Shun, C. T., Lee, W. J., and Lin, J. T. (1997) Loss of imprinting and overexpression of IGF2 gene in gastric adenocarcinoma. Cancer Lett. 120, 9-14.
54. Randhawa, G. S., Cui, H., Barletta, J. A., Strichman-Almashanu, L. Z., Talpaz, M., Kantarjian, H., Deisseroth, A. B., Champlin, R. C., and Feinberg, A. P. (1998) Loss of imprinting in disease progression in chronic myelogenous leukemia. Blood 91, 3144-3147.
55. Rainier, S., Johnson, L. A., Dobry, C. J., Ping, A. J., Grundy, P. E., and Feinberg, A. P. (1993) Relaxation of imprinted genes in human cancer. Nature 362, 747-749.
56. Sun, F. L., Dean, W. L., Kelsey, G., Allen, N. D., and Reik, W. (1997) Transactivation of IGF2 in a mouse model of Beckwith-Wiedemann syndrome. Nature 389, 809-815.
57. Pilia, G., Hughes-Benzie, R. M., MacKenzie, A., Baybayan, P., Chen, E. Y., Huber, R., Neri, G., Cao, A., Forabosco, A., and Schlessinger, D. (1996) Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nature Genet. 12, 241-247.
58. DeChiara, T. M., Robertson, E. J., and Efstratiadis, A. (1991) Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64, 849-859.
59. Hatada, I. and Mukai, T. (1995) Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse. Nature Genet. 11, 204-206.
60. Matsuoka, S., Thompson, J. S., Edwards, M. C., Bartletta, J. M., Grundy, P., Kalikin, L. M., Harper, J. W., Elledge, S. J., and Feinberg, A. P. (1996) Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15. Proc. Natl. Acad. Sci. USA 93, 3026-3030.
61. Kitsberg, D., Selig, S., Brandeis, M., Simon, I., Keshet, I., Driscoll, D. J., Nicholls, R. D., and Cedar, H. (1993) Allele-specific replication timing of imprinted gene regions. Nature 364, 459-463.
62. Zhou, Q. Y., Quaife, C. J., and Palmiter, R. D. (1995) Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature 374, 640-643.
63. Kobayashi, K., Morita, S., Sawada, H., Mizuguchi, T., Yamada, K., Nagatsu, I., Hata, T., Watanabe, Y., Fujita, K., and Nagatsu, T. (1995) Targeted disruption of the tyrosine hydroxylase locus results in severe catecholamine depletion and perinatal lethality in mice. J. Biol. Chem. 270, 27,235-27,243.
64. Caspary, T., Cleary, M. A., Baker, C. C., Guan, X.-J., and Tilghman, S. M. (1998) Multiple mechanisms regulate imprinting of the mouse distal chromosome 7 gene cluster. Mol. Cell. Biol. 18, 3466-3474.
65. Nicholls, R. D. (1994) New insights reveal complex mechanisms involved in genomic imprinting. Am. J. Hum. Genet. 54, 733-740.
66. Albrecht, U., Sutcliffe, J. S., Cattanach, B. M., Beechey, C. V., Armstrong, D., Eichele, G., and Beaudet, A. L. (1997) Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons. Nature Genet. 17, 75-78.
67. Rougeulle, C., Glatt, H., and Lalande, M. (1997) The Angelman syndrome candidate gene, UBE3A/E6-AP, is imprinted in brain. Nature Genet. 17, 14-15.
68. Vu, T. H. and Hoffman, A. R. (1997) Imprinting of the Angelman syndrome gene, UBE3A, is restricted to brain. Nature Genet. 17, 12-13.
69. Qian, N., Frank, D., O'Keefe, D., Dao, D., Zhao, L., Yuan, L., Wang, Q., Keating, M., Walsh, C., and Tycko, B. (1997) The IPL gene on chromosome 11p15.5 is imprinted in humans and mice and is similar to TDAG51, implicated in Fas expression and apoptosis. Hum. Mol. Genet. 6, 2021-2029.
70. Lee, M. P. and Feinberg, A. P. (1998) Genomic imprinting of a human apoptosis gene homologue, TSSC3. Cancer Res. 58, 1052-1056.
71. Dao, D., Frank, D., Qian, N., O'Keefe, D., Vosatka, R. J., Walsh, C. P., and Tycko, B. (1998) IMPTI, an imprinted gene similar to polyspecific transporter and multi-drug resistance genes. Hum. Mol. Genet. 7, 597-608.
72. Schwienbacher, C., Sabbioni, S., Campi, M., Veronese, A., Bernardi, G., Menegatti, A., Hatada, I., Mukai, T., Ohashi, H., Barbanti-Brodano, G., Croce, C. M., and Negrini, M. (1998) Transcriptional map of 170-kb region at chromosome 11p15.5: Identification and mutational analyzis of the BWR1 A gene reveals the presence of mutations in tumor samples. Proc. Natl. Acad. Sci. USA 95, 3873-3878.
73. Horsthemke, B. (1997) Structure and function of the human chromosome 15 imprinting center. J. Cell Physiol. 173, 237-241.
74. Horsthemke, B., Dittrich, B., and Buiting, K. (1997) Imprinting mutations on human chromosome 15. Hum. Mutat. 10, 329-337.
75. Reik, W., Brown, K. W., Schneid, H., Lebouc, Y., Bickmore, W., and Maher, E. W. (1995) Imprinting mutations in the Beckwith-Wiedemann syndrome suggested by an altered imprinting pattern in the IGF2-H19 domain. Hum. Mol. Genet. 4, 2379-2385.
76. Leighton, P. A., Saam, J. R., Ingram, R. S., Stewart, C. L., and Tilghman, S. M. (1995) An enhancer deletion affects both H19 and IGF2 expression. Genes Dev. 9, 2079-2089.
77. Leighton, P. A., Ingram, R. S., Eggenschwiler, J., Efstratiadis, A., and Tilghman, S. M. (1995) Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 375, 34-39.
78. Forné, T., Oswald, J., Dean, W., Saam, J. R., Bailleul, B., Dandolo, L., Tilghman, S. M., Walter, J., and Reik, W. (1997) Loss of the maternal H19 gene induces changes in IGF2 methylation in both cis and trans. Proc. Natl. Acad. Sci. USA 94, 10,243-10,248.
79. Ripoche, M. A., Kress, C., Poirier, F., and Dandolo, L. (1997) Deletion of the H19 transcription unit reveals the existence of a putative imprinting control element. Genes Dev. 11, 1596-1604.
80. Mannens, M., Alders, M., Redeker, B., Blick, J., Steenman, M., Wiesmeyer, C., de Meulemeester, M., Ryan, A., Kalikin, L., Voute, T., De Kraker, J., Hoovers, J., Slater, R., Feinberg, A., Little, P., and Westerveld, A. (1996) Positional cloning of genes involved in the Beckwith-Wiedemann syndrome, hemihypertrophy, and associated childhood tumors. Med. Pediatr. Oncol. 27, 490-494.
81. Lee, M. P., Hu, R. J., Johnson, L. A., and Feinberg, A. P. (1997) Human KVLQTI gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements. Nature Genet. 15, 181-185.
82. Dittrich, B., Buiting, K., Korn, B., Rickard, S., Buxton, J., Saitoh, S., Nicholls, R. D., Poustka, A., Winterpacht, A., Zabel, B., and Horsthemke, B. (1996) Imprint switching on human chromosome 15 may involve alternative transcripts of the SNRPN gene. Nature Genet. 14, 163-170.
83. Schulze, A., Hansen, C., Skakkeback, N. E., Brondum-Nielsen, K., Ledbeter, D. H., and Tommerup, N. (1996) Exclusion of SNRPN as a major determinant of Prader-Willi syndrome by a translocation breakpoint. Nature Genet. 12, 452-454.
84. Burke, L. W., Wiley, J. E., Glenn, C. C., Driscoll, D. J., Loud, K. M., Smith, A. J., and Kushnick, T. (1996) Familial cryptic translocation resulting in Angelman syndrome: Implications for imprinting or location of the Angelman gene? Am. J. Hum. Genet. 58, 777-784.
85. Sun, Y., Nicholls, R. D., Butler, M. G., Saitoh, S., Hainline, B. E., and Palmer, C. G. (1996) Breakage in the SNRPN locus in a balanced 46,XY,t(15;19) Prader-Willi syndrome patient. Hum. Mol. Genet. 5, 517-524.
86. Greger, V., Knoll, J. H., Wagstaff, J., Woolf, E., Lieske, P., Glatt, H., Benn, P. A., Rosengren, S. S., and Lalande, M. (1997) Angelman syndrome associated with an inversion of chromosome 15q11.2q24.3. Am. J. Hum. Genet. 60, 574-580.
87. Conroy, J. M., Grebe, T. A., Becker, L. A., Tsuchiya, K., Nicholls, R. D., Buiting, K., Horsthemke, B., Cassidy, S. B., and Schwartz, S. (1997) Balanced translocation 46,XY,t(2;15)(q37.2;q11.2) associated with atypical Prader-Willi syndrome. Am. J. Hum. Genet. 61, 388-394.
88. Tsang, P., Gilles, F., Yuan, L., Kuo, Y.-H., Lupu, F., Samara, G., Moosikasuwan, J., Goye, A., Zelenetz, A.D., Selleri, L., and Tycko, B. (1995) A novel L23-related gent 40 kb downstream of the imprinted H19 gene is biallelically expressed in mid-fetal and adult human tissues. Hum. Mol. Genet. 4, 1499-1507.
89. Yuan, L., Qian, N., and Tycko, B. (1996) An extended region of biallelic gene expression and rodenthuman synteny downstream of the imprinted H19 gene on chromosome 11p15.5. Hum. Mol. Genet. 5, 1931-1937.
90. Greally, J. M., Starr, D. J., Hwang, S., Song, L., Jaarola, M., and Zemel, S. (1998) The mouse H19 locus mediates a transition between imprinted and non- imprinted DNA replication patterns. Hum. Mol. Genet. 7, 91-96.
91. Jackson, D. A. and Pombo, A. (1998) Replicon clusters are stable units of chromosome structure: Evidence that nuclear organization contributes to the efficient activation and propagation of S phase in human cells. J. Cell Biol. 140, 1285-1295.
92. Laemnlli, U. K., Kas, E., Poljak, L., and Adachi, Y. (1992) Scaffold-associated regions: Cis-acting determinants of chromatin structural loops and functional domains. Curr. Opin. Genet. Dev. 2, 275-285.
93. Kellum, R. and Schedl, P. (1992) A group of scs elements function as domain boundaries in an enhancer-blocking assay. Mol. Cell. Biol. 12, 2424-2431.
94. Cockerill, P. N. and Garrard, W. T. (1986) Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites. Cell 44, 273-282.
95. Poljak, L., Seum, C., Mattioni, T., and Laemmli, U.K. (1994) SARs stimulate but do not confer position independent gene expression. Nucleic Acids Res. 22, 4386-4394.
96. Greally, J. M., Guinness, M. E., McGrath, J., and Zemel, S. (1997) Matrix-attachment regions in the mouse chromosome 7F imprinted domain. Mamm. Genome 8, 805-810.
97. Pfeifer, K., Leighton, P. A., and Tilghman, S. M. (1996) The structural H19 gene is required for transgene imprinting. Proc. Natl. Acad. Sci. USA 93, 13,876-13,883.
98. Elson, D. A. and Bartolomei, M. S. (1997) A 5′ differentially methylated sequence and the 3′-flanking region are necessary for H19 transgene imprinting. Mol. Cell Biol. 17, 309-317.
99. Kellum, R. and Schedl, P. (1991) A position-effect assay for boundaries of higher order chromosomal domains. Cell 64, 941-950.
100. Zemel, S., Bartolomei, M. S., and Tilghman, S. M. (1992) Physical linkage of two mammalian imprinted genes, H19 and insulin-like growth factor 2. Nature Genet. 2, 61-65.
101. Yoo-Warren, H., Pachnis, V., Ingram, R. S., and Tilghman, S. M. (1988) Two regulatory domains flank the mouse H19 gene. Mol. Cell. Biol. 8, 4707-4715.
102. Webber, A. L., Ingrain, R. S., Levorse, J. M., and Tilghman, S. M. (1998) Location of enhancers is essential for the imprinting of H19 and IGF2 genes. Nature 391, 711-715.
103. Panning, B., Dausman, J., and Jaenisch, R. (1997) X chromosome inactivation is mediated by Xist RNA stabilization. Cell 90, 907-916.
104. Brannan, C. I., Dees, E. C., Ingram, R. S., and Tilghman, S. M. (1990) The product of the H19 gene may function as an RNA. Mol. Cell. Biol. 10, 28-36.
105. Jinno, Y., Sengoku, K., Nakao, M., Tamate, K., Miyamoto, T., Matsuzaka, T., Sutcliffe, J. S., Anan, T., Takuma, N., Nishiwaki, K., Ikeda, Y., Ishimaru, T., Ishikawa, M., and Niikawa, N. (1996) Mouse/human sequence divergence in a region with a paternal-specific methylation imprint at the human H19 locus. Hum. Mol. Genet. 5, 1155-1161.
106. Lyko, F., Brenton, J. D., Surani, M. A., and Paro, R. (1997) An imprinting element from the mouse H19 locus functions as a silcncer in Drosophila. Nature Genet. 16, 171-173.
107. Wines, D. R., Talbert, P. B., Clark, D. V., and Henikoff, S. (1996) Introduction of a DNA methyltransferase into Drosophila to probe chromatin structure in vivo. Chromosoma 104, 332-340.
108. Pfeifer, K. and Tilghman, S. M. (1994) Allele-specific gene expression in mammals: The curious case of the imprinted RNAs. Genes Dev. 8, 1867-1874.
109. Hagstrom, K., Muller, M., and Schedl, P. (1996) Fab-7 functions as a chromatin domain boundary to ensure proper segment specification by the Drosophila bithorax complex. Genes Dev. 10, 3202-3215.
110. Roseman, R. R., Pirrotta, V., and Geyer, P. K. (1993) The su(Hw) protein insulates expression of the Drosophila melanogaster white gene from chromosomal position-effects. EMBO J. 12, 435-442.
111. Chung, J. H., Whiteley, M., and Felsenfeld, G. (1993) A 5′ element of the chicken beta-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila. Cell 74, 505-514.
112. Zhong, X.-P. and Krangel, M. S. (1997) An enhancer-blocking element between α and δ gene segments within the human T cell receptor α/δ locus. Proc. Natl. Acad. Sci. USA 94, 5219-5224.
113. Geyer, P. K. (1997) The role of insulator elements in defining domains of gene expression. Curr. Opm. Genet. Dev. 7, 242-248.
114. Gerasimova, T. I. and Corces, V. G. (1998) Polycomb and trithorax group proteins mediate the function of a chromatin insulator. Cell 92, 511-521.
115. Gerasimova, T. I., Gdula, D. A., Gerasimov, D. V., Simonova, O., and Corces, V. G. (1995) A Drosophila protein that imparts directionality on a chromatin insulator is an enhancer of position-effect variegation. Cell 82, 587-597.
116. Chung, J. H., Bell, A. C., and Felsenfeld, G. (1997) Characterization of the chicken beta-globin insulator. Proc. Natl. Acad. Sci. USA 94, 575-580.
117. Wang, Y., DeMayo, F. J., Tsai, S. Y., and O'Malley, B. W. (1997) Ligand-inducible and liver-specific target gene expression in transgenic mice. Nature Biotech. 15, 239-243.
118. Vazquez, J. and Schedl, P. (1994) Sequences required for enhancer blocking activity of ses are located within two nuclease-hypersensitive regions. EMBO J. 13, 5984-5993.
119. Tremblay, K. D., Duran, K. L., and Bartolomei, M. S. (1997) A 5′ 2-kilobase-pair region of the imprinted mouse H19 gene exhibits exclusive paternal methylation throughout development. Mol. Cell. Biol. 17, 4322-4329.
120. Ferguson-Smith, A. C., Sasaki, H., Cattanach, B. M., and Surani, M. A. (1993) Parental-origin-specific epigenetic modification of the mouse H19 gene. Nature 362, 751-755.
121. Steenman, M. J., Rainier, S., Dobry, C. J., Grundy, P., Horon, I. L., and Feinberg, A. P. (1994) Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumor. Nature Genet. 7, 433-439.
122. Taniguchi, T., Sullivan, M. J., Ogawa, O., and Reeve, A. E. (1995) Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor. Proc. Natl. Acad. Sci. USA 92, 2159-2163.
123. Ainscough, J. F., Koide, T., Tada, M., Barton, S., and Surani, M. A. (1997) Imprinting of IGF2 and H19 from a 130 kb YAC transgene. Development 124, 3621-3632.
124. Bartolomei, M. S., Webber, A. L., Brunkow, M. E., and Tilghman, S. M. (1993) Epigenetic mechanisms underlying the imprinting of the mouse HI9 gene. Genes Dev. 7, 1663-1673.
125. Reid, L. H., Davies, C., Cooper, P. R., Crider-Miller, S. J., Sait, S. N., Nowak, N. J., Evans, G., Stanbridge, E. J., deJong, P., Shows, T. B., Weissman, B. E., and Higgins, M. J. (1997) A 1-Mb physical map and PAC contig of the imprinted domain in 11p15.5 that contains TAPAI and the BWSCRI/WT2 region. Genomics 43, 366-375.